AstraZeneca (AstraZeneca) 5-Year EBITDA Growth Rate : 6.40% (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca 5-Year EBITDA Growth Rate?

AstraZeneca's EBITDA per Share for the three months ended in Dec. 2023 was $0.70.

During the past 12 months, AstraZeneca's average EBITDA Per Share Growth Rate was 42.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 14.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 6.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of AstraZeneca was 28.20% per year. The lowest was -27.30% per year. And the median was 6.50% per year.

Competitive Comparison of AstraZeneca's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, AstraZeneca's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AstraZeneca's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where AstraZeneca's 5-Year EBITDA Growth Rate falls into.

AstraZeneca 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

AstraZeneca (NAS:AZN) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

AstraZeneca 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of AstraZeneca's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca (AstraZeneca) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.